ArticleCancer management and research2019

A new predictor is comparable to the updated nomogram in predicting the intermediate- and high-risk prostate cancer but outperforms nomogram in reducing the overtreatment for the low-risk Pca.

Hui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.